NCT01614002View on ClinicalTrials.gov

A Non Interventional Study With Doce Onkovis (Docetaxel) Utilized for the Treatment of Cancer

CompletedOBSERVATIONAL

Enrollment

371

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

March 31, 2015

Study Completion Date

March 31, 2015

Conditions

Carcinoma

Trial Locations (23)

13156

Practice, Berlin

14770

Practice, Brandenburg

15517

Practice, Fürstenwalde

19370

Practice, Parchim

39104

Practice, Magdeburg

96317

Practice, Kronach

98617

Practice, Meiningen

99974

Practice, Mühlhausen

09117

Practice, Chemnitz

03055

Practice, Cottbus

01307

Practice, Dresden

01920

Practice, Elstra

01705

Practice, Freital

06132

Practice, Halle

06366

Practice, Köthen

04277

Hospital, Leipzig

Practice, Leipzig

08525

Practice, Plauen

09481

Practice, Scheibenberg

04860

Clinic, Torgau

08412

Practice, Werdau

02763

Practice, Zittau

08060

Practice, Zwickau

All Listed Sponsors

collaborator

AKP Freiburg GmbH

INDUSTRY

lead

Onkovis GmbH

INDUSTRY

NCT01614002 - A Non Interventional Study With Doce Onkovis (Docetaxel) Utilized for the Treatment of Cancer | Biotech Hunter | Biotech Hunter